Misplaced Pages

Edward Tobinick: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 21:38, 14 December 2020 editTom.Bot (talk | contribs)Bots211,008 editsm Task 6: +{{Authority control}}, WP:GenFixes onTag: AWB← Previous edit Revision as of 20:23, 5 March 2021 edit undoPythagimedes (talk | contribs)Extended confirmed users1,234 edits not relevant or helpful for this specific articleTags: Mobile edit Mobile web edit Advanced mobile editNext edit →
Line 10: Line 10:


'''Edward Tobinick''' M.D. is an American ], ], and ], who invented the use of the drug ] for chronic neurological dysfunction after ] and ],<ref>{{cite news |last=Singh |first=Anita| title= Andrew Marr: how having a stroke changed my marriage for the better |url=https://www.telegraph.co.uk/news/2017/02/07/andrew-marr-having-stroke-changed-marriage-better/ |accessdate=November 17, 2018 |newspaper=]|date=February 7, 2017 }}</ref><ref>{{cite news |publisher=Springer Select |date=October 31, 2012 |title=New hope for survivors of stroke and traumatic brain injury | url=https://www.springer.com/about+springer/media/springer+select?SGWID=0-11001-6-1394543-0 |accessdate=November 17, 2018 }}</ref> with multiple issued U.S. and foreign patents, including U.S. patent 8,900,583. '''Edward Tobinick''' M.D. is an American ], ], and ], who invented the use of the drug ] for chronic neurological dysfunction after ] and ],<ref>{{cite news |last=Singh |first=Anita| title= Andrew Marr: how having a stroke changed my marriage for the better |url=https://www.telegraph.co.uk/news/2017/02/07/andrew-marr-having-stroke-changed-marriage-better/ |accessdate=November 17, 2018 |newspaper=]|date=February 7, 2017 }}</ref><ref>{{cite news |publisher=Springer Select |date=October 31, 2012 |title=New hope for survivors of stroke and traumatic brain injury | url=https://www.springer.com/about+springer/media/springer+select?SGWID=0-11001-6-1394543-0 |accessdate=November 17, 2018 }}</ref> with multiple issued U.S. and foreign patents, including U.S. patent 8,900,583.

On October 6, 2018, ] MP, the ], announced that his government was allocating funds specifically for the study of perispinal ] for the rehabilitation of stroke survivors in ].<ref>{{cite news |newspaper=SBS News | date=October 6, 2018 | title= Stroke drug trial set for Australia |url=https://www.sbs.com.au/news/stroke-drug-trial-set-for-australia |accessdate=November 17, 2018 }}</ref><ref>{{cite web |last=Hunt MP |first=Greg |date=October 6, 2018 |title=$1 million to support the rehabilitation of stroke survivors |publisher=Australia Ministry of Health |accessdate=November 17, 2018 |url=http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt134.htm}}</ref>


== Selected publications == == Selected publications ==

Revision as of 20:23, 5 March 2021

Edward Tobinick
BornNew York City, US
NationalityAmerican
Alma materBrandeis University (B.S. Biology, 1973)
UC San Diego School of Medicine (M.D., 1977)
OccupationPhysician
Known forPerispinal Etanercept
Websitehttp://www.nrimed.com

Edward Tobinick M.D. is an American physician, inventor, and scientist, who invented the use of the drug etanercept for chronic neurological dysfunction after stroke and brain injury, with multiple issued U.S. and foreign patents, including U.S. patent 8,900,583.

Selected publications

Year Article Journal / Textbook
2010 Edward Tobinick, Perispinal Etanercept: A New Therapeutic Paradigm in Neurology.   Expert Review of Neurotherapeutics 2010 Jun;10(6):985-1002.
2011 Edward Tobinick, Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.   CNS Drugs 2011, 25(2): p. 145-55.
2012 Tobinick, E., N.M. Kim, G. Reyzin, H. Rodriguez-Romanacce, and V. DePuy, Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.   CNS Drugs 2012, 26(12): p. 1051–70.
2014 Ignatowski, T.A., R.N. Spengler, K.M. Dhandapani, H. Folkersma, R.F. Butterworth, and E. Tobinick, Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.   CNS Drugs 2014, 25(2): p. 145-55.
2014 Tobinick, E., H. Rodriguez-Romanacce, A. Levine, T.A. Ignatowski, and R.N. Spengler, Immediate neurological recovery following perispinal etanercept years after brain injury.   Clin Drug Investig 2014, 34(5): p. 361-6.
2016 Edward Tobinick, Perispinal Delivery of CNS Drugs.   CNS Drugs 2016 Jun;30(6):469-80.
2017 Tobinick, E., H. Rodriguez-Romanacce, R. Kinssies, and N.M. Kim, Chapter 7 - Perispinal Etanercept for Traumatic Brain Injury.   New Therapeutics for Traumatic Brain Injury, K.A. Heidenreich, Editor. 2017, Academic Press/Elsevier: New York.
2018 Edward Tobinick, Perispinal etanercept advances as a neurotherapeutic.   Expert Review of Neurotherapeutics 2018, 18(6): p. 453-455.

References

  1. Singh, Anita (February 7, 2017). "Andrew Marr: how having a stroke changed my marriage for the better". The Telegraph. Retrieved November 17, 2018.
  2. "New hope for survivors of stroke and traumatic brain injury". Springer Select. October 31, 2012. Retrieved November 17, 2018.

Selected patents

Year Issued Inventor Title Country
2009 Edward Tobinick Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers. U.S. Patent 7,629,311”   US
2014 Edward Tobinick Methods for treatment of brain injury using biologics. U.S. Patent 8,900,583   US
Categories: